Interaction between CDC6 and Tmod3 accelerates resistance to paclitaxel through focal adhesion assembly

Yue Liu1,2, Huirui Wang1, Jie Zhan1

  • 1Key Laboratory of Natural Products & Chemical Biology, Ministry of Education, School of Pharmaceutical Sciences, Shandong University, Jinan, China.

Insights

Cell division cycle 6 (CDC6) drives paclitaxel (PTX) resistance by regulating cell adhesion and the actin cytoskeleton. Depleting CDC6 sensitizes cancer cells to PTX, offering a new therapeutic strategy.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Paclitaxel (PTX) resistance and drug-tolerant persister cells limit its cancer treatment efficacy.
  • Identifying novel regulators of PTX resistance is crucial for improving therapeutic outcomes.

Purpose of the Study:

  • To systematically identify key regulators of paclitaxel resistance using a genome-wide screen.
  • To elucidate the novel mechanisms by which CDC6 confers PTX resistance.

Main Methods:

  • Genome-wide CRISPR/Cas9 knockout screen to identify resistance regulators.
  • Genetic depletion of CDC6 and assessment of PTX sensitivity.
  • Investigation of CDC6 interaction with Tmod3 and its role in cytoskeleton remodeling and focal adhesion assembly.
  • Combination treatment studies with PTX and actin filament inhibitors in vitro and in vivo.

Main Results:

  • Cell division cycle 6 (CDC6) was identified as a critical determinant of cell adhesion-mediated PTX resistance.
  • CDC6 functions through a novel pathway, distinct from known resistance mechanisms.
  • Genetic depletion of CDC6 significantly sensitized cells to PTX, increasing cell death.
  • CDC6 interacts with Tmod3, enhancing its stability and promoting drug resistance via actin cytoskeleton remodeling and focal adhesion assembly.
  • Combination therapy with PTX and actin inhibitors showed synergistic antitumor effects.

Conclusions:

  • CDC6 is a key regulator of PTX resistance, operating through cytoskeletal and adhesion pathways.
  • Targeting CDC6 or the cytoskeletal-adhesion axis presents a promising strategy to overcome PTX resistance and enhance cancer treatment efficacy.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
5.7K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.3K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
3.4K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.9K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.0K